SCHEMBL2363693

SCHEMBL2363693

O=C(O[N+]1(O)C(=O)CCC1=O)c1cccnc1Cl

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.49
SMN1; SMN2 Q16637 2/20 0.49
POLB P06746 1/20 0.48
L3MBTL1 Q9Y468 3/20 0.47
CYP1A2 P05177 2/20 0.46
CYP2C9 P11712 2/20 0.46
CYP2C19 P33261 2/20 0.46
CASP3 P42574 1/20 0.46
SENP8 Q96LD8 1/20 0.46
SENP7 Q9BQF6 1/20 0.46
SENP6 Q9GZR1 1/20 0.46
ALDH1A1 P00352 2/20 0.44
KMT2A Q03164 5/20 0.44
MEN1 O00255 4/20 0.44
TDP1 Q9NUW8 3/20 0.43
CYP2D6 P10635 1/20 0.43
PKM P14618 1/20 0.43
RAB9A P51151 1/20 0.43
AGTR1 P30556 1/20 0.42
HTT P42858 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2362867 0.83 NAPRT (0.49) LMNASMN1; SMN2L3MBTL1CASP3SENP8
SCHEMBL2362643 0.79 SMN1; SMN2 (0.46) LMNASMN1; SMN2POLBL3MBTL1CYP1A2
SCHEMBL1078138 0.74 KMT2A (0.35) LMNASMN1; SMN2ALDH1A1KMT2AMEN1
SCHEMBL14459991 0.73 LMNA (0.63) LMNASMN1; SMN2POLBL3MBTL1CYP1A2
SCHEMBL2363364 0.73 CES2 (0.44) LMNAL3MBTL1ALDH1A1KMT2AMEN1
SCHEMBL624343 0.72 LMNA (0.61) LMNASMN1; SMN2POLBL3MBTL1CYP1A2
SCHEMBL29412879 0.72 LMNA (0.61) LMNASMN1; SMN2POLBL3MBTL1CYP1A2
SCHEMBL28764965 0.72 LMNA (0.61) LMNASMN1; SMN2POLBL3MBTL1CYP1A2
Cyclohexane SCHEMBL28734389 0.71 LMNA (0.56) LMNASMN1; SMN2POLBL3MBTL1CYP1A2
SCHEMBL9244299 0.71 AKR1C3 (0.47) SMN1; SMN2L3MBTL1CYP1A2CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7989430-B2 Antibacterial agents REGENTS OF THE UNIVERSITY OF MINNESOTA (US) 2011-08-02 US disclosed
US-20080293666-A1 Antibacterial Agents REGENTS OF THE UNIVERSITY OF MINNESOTA (US) 2008-11-27 US disclosed
EP-1960518-A2 ANTIBACTERIAL AGENTS REGENTS OF THE UNIVERSITY OF MINNESOTA (US) 2008-08-27 EP disclosed
WO-2007067559-A2 ANTIBACTERIAL AGENTS REGENTS OF THE UNIVERSITY OF MINNESOTA (US) 2007-06-14 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080293666-A1 Antibacterial Agents MRPL21, ABCB7, MSR1 LMNA 2265/4885SMN1; SMN2 4231/4885POLB 933/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.